Skaggs School of Pharmacy and Pharmaceutical Sciences, School of Medicineqa.
Department of Cellular and Molecular Medicine, School of Medicine.
Mol Biol Cell. 2022 Mar 1;33(3):vo1. doi: 10.1091/mbc.E21-10-0507.
Despite substantial investment and effort by federal agencies and institutions to improve the diversity of the professoriate, progress is excruciatingly slow. One program that aims to enhance faculty diversity is the Institutional Research and Academic Career Development Award (IRACDA) funded by the National Institutes of Health/National Institute of General Medical Sciences. IRACDA supports the training of a diverse cohort of postdoctoral scholars who will seek academic research and teaching careers. The San Diego IRACDA program has trained 109 postdoctoral scholars since its inception in 2003; 59% are women and 63% are underrepresented (UR) Black/African-American, Latinx/Mexican-American, and Indigenous scientists. Sixty-four percent obtained tenure-track faculty positions, including a substantial 32% at research-intensive institutions. However, the COVID-19 pandemic crisis threatens to upend IRACDA efforts to improve faculty diversity, and academia is at risk of losing a generation of diverse, talented scholars. Here, a group of San Diego IRACDA postdoctoral scholars reflects on these issues and discusses recommendations to enhance the retention of UR scientists to avoid a "lost generation" of promising UR faculty scholars.
尽管联邦机构和机构在提高教授队伍的多样性方面投入了大量的资金和精力,但进展却非常缓慢。一个旨在增强教师多样性的项目是由美国国立卫生研究院/国家普通医学科学研究所资助的机构研究和学术职业发展奖(IRACDA)。IRACDA 支持培训一批多元化的博士后学者,他们将寻求学术研究和教学职业。圣地亚哥 IRACDA 计划自 2003 年成立以来已经培训了 109 名博士后学者;其中 59%是女性,63%是代表性不足的(UR)黑/非裔美国人、拉丁裔/墨西哥裔和土著科学家。64%的人获得了终身教职,其中包括在研究密集型机构任职的人数相当多的 32%。然而,COVID-19 大流行危机有可能打乱 IRACDA 改善教师多样性的努力,学术界面临着失去一代多元化、有才华的学者的风险。在这里,一群圣地亚哥 IRACDA 博士后学者反思了这些问题,并讨论了加强留住 UR 科学家的建议,以避免出现“失去的一代”有前途的 UR 教师学者。